The Toronto oncological MRI agent spinout has been backed by Facit’s Prospects Oncology vehicle, to target applications including the identification and treatment of tumours in the brain.
Nanology Labs, a Canada-based MRI imaging agent spinout of University of Toronto, has secured an undisclosed amount of funding from commercialisation unit Fight Against Cancer Innovation Trust’s (Facit’s) Prospects Oncology Fund.
Founded in 2015, Nanology Labs has devised a nanotechnology-powered contrasting agent for MRI scans that exploits the mineral manganese to delineate early-stage tumours in areas including the brain, where it is able to bypass the blood-brain-barrier.
In addition to facilitating better clinical decisions, the agent induces oxygen…
